Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Innoviva is a US pharmaceutical company that earns royalties from GSK respiratory drugs such as Relvar/Breo Ellipta and Anoro Ellipta. Through Innoviva Specialty Therapeutics it also markets medicines for serious infectious diseases.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Innoviva is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Innoviva last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.
Across its last 3 earnings reports, Innoviva stock moved by ±5.7% on average the following day. The largest reaction was +12.9% on 11/05/2025; 2 of 3 reactions were positive.
Innoviva has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.